vizamyl has been researched along with Alzheimer-Disease* in 1 studies
1 review(s) available for vizamyl and Alzheimer-Disease
| Article | Year |
|---|---|
Near-Infrared Fluorescent Probes as Imaging and Theranostic Modalities for Amyloid-Beta and Tau Aggregates in Alzheimer's Disease.
A person suspected of having Alzheimer's disease (AD) is clinically diagnosed for the presence of principal biomarkers, especially misfolded amyloid-beta (Aβ) and tau proteins in the brain regions. Existing radiotracer diagnostic tools, such as PET imaging, are expensive and have limited availability for primary patient screening and pre-clinical animal studies. To change the status quo, small-molecular near-infrared (NIR) probes have been rapidly developed, which may serve as an inexpensive, handy imaging tool to comprehend the dynamics of pathogenic progression in AD and assess therapeutic efficacy Topics: Alzheimer Disease; Amyloid beta-Peptides; Animals; Fluorescent Dyes; Humans; Precision Medicine; tau Proteins | 2022 |